Dr. Lydia L. Sohn's lab at UC Berkeley explores the mechanical properties of breast epithelial cells to understand breast cancer susceptibility. The lab combines cutting-edge technology to measure how these properties change with age and genetic risk factors. By developing a novel platform called mechano-NPS, they aim to improve breast cancer detection methods beyond traditional genetic testing.

Dr. Amy J. Pickering's lab focuses on improving maternal and neonatal health in sub-Saharan Africa by addressing water quality and hygiene in rural health facilities. They have developed an innovative, low-cost chlorination technology that disinfects water automatically, aiming to reduce infections that threaten newborns and mothers. The lab conducts rigorous trials to assess the effectiveness of this intervention in improving health outcomes and minimizing antibiotic resistance.

Dr. Chunlei Liu's lab at UC Berkeley focuses on understanding and manipulating the roles of astrocytes, the brain's most abundant cells, in health and disease. They aim to develop advanced technologies for precise control of calcium signaling in astrocytes, which is crucial for neuronal interactions and brain function. The lab also innovates in MRI technology to enhance imaging capabilities for neurological conditions, including Alzheimer's disease, by creating programmable MRI coils that improve brain imaging and diagnosis.

Dr. Jun-Chau Chien's research lab focuses on developing innovative point-of-care (POC) diagnostic systems that can rapidly detect biomarkers directly at the site of patient care. By integrating miniaturized technology and advanced molecular sensing techniques, the lab aims to create portable devices that can analyze unprocessed samples like urine. This research holds particular significance for resource-limited settings, especially in improving maternal health outcomes through early detection of conditions like preeclampsia.

Dr. David Schaffer's lab at UC Berkeley focuses on developing advanced gene therapy techniques specifically targeting microglia in the brain. They are working on engineering adeno-associated viral vectors to deliver therapeutic genes selectively to microglia cells, which are critically involved in various neurological disorders. Their research combines cutting-edge technologies like machine learning, single-cell sequencing, and viral engineering to create targeted treatments that may help manage conditions like Alzheimer's and autism.

Dr. Yun S. Song's lab focuses on developing advanced computational methods to analyze and interpret large genomic data sets. This research aims to enhance our understanding of molecular evolution and genetic variations across different timescales, especially in relation to human health. The lab works on creating user-friendly software tools that can help biomedical researchers leverage genomic data for significant discoveries, particularly in cancer biology and immune responses.

Dr. Jay D. Keasling's lab focuses on developing improved vaccines by designing better adjuvants, which are substances that enhance the immune response to vaccine antigens. The research combines synthetic biology techniques to engineer yeast for adjuvant production with systems immunology to understand how these adjuvants work at the molecular level. This interdisciplinary approach aims to create innovative solutions for preventing and treating diseases.